Sio Gene Therapies Inc. SIOX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

26/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

共有 50 笔近期内部人交易记录记录，涉及 Sio Gene Therapies Inc. (SIOX), 包括 29 笔买入 和 11 笔卖出. 内部人买入总额为 $24.85M 内部人卖出总额为 $609.68K.

近期活跃的重要内部人包括 Nassif David W., Meswani Parag V, Cheruvu Pavan. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — SIOX

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2022-02-08	Nassif David W.	Interim CEO, CFO	限制性股票授予 (RSU)	546,500	-	-	546,500
2022-02-08	Meswani Parag V	Chief Commercial Officer	限制性股票授予 (RSU)	153,700	-	-	153,700
2022-01-28	Meswani Parag V	Chief Commercial Officer	处置	219,000	$2.47	$540.93K	-
2021-12-08	Nassif David W.	Chief Financial Officer	股份退回	17,534	-	-	35,066
2021-12-08	Cheruvu Pavan	Chief Executive Officer	股份退回	37,567	-	-	75,133
2021-04-15	Vuori Kristiina Md	Director	限制性股票授予 (RSU)	42,000	$2.47	$103.74K	42,000
2021-04-15	Nassif David W.	Chief Financial Officer	限制性股票授予 (RSU)	239,000	$2.47	$590.33K	239,000
2021-04-15	Pande Atul	Director	限制性股票授予 (RSU)	42,000	$2.47	$103.74K	42,000
2021-04-15	Modig Berndt	Director	限制性股票授予 (RSU)	42,000	$2.47	$103.74K	42,000
2021-04-15	Torti Frank	Director	限制性股票授予 (RSU)	42,000	$2.47	$103.74K	42,000
2021-04-15	Cheruvu Pavan	Chief Executive Officer	限制性股票授予 (RSU)	682,100	$2.47	$1.68M	682,100
2021-04-15	Corcoran Gavin	Chief R&d Officer	限制性股票授予 (RSU)	244,300	$2.47	$603.42K	244,300
2021-04-15	Sundaram Senthil Vel	Director	限制性股票授予 (RSU)	42,000	$2.47	$103.74K	42,000
2021-03-23	Cheruvu Pavan	Chief Executive Officer	知情买入	100,000	$2.48	$248.18K	180,426
2021-03-22	Nassif David W.	Chief Financial Officer	股份退回	15,060	-	-	-
2021-03-17	Cheruvu Pavan	Chief Executive Officer	股份退回	22,590	-	-	-
2021-03-17	Corcoran Gavin	Chief R&d Officer	股份退回	16,001	-	-	-
2020-11-24	Pande Atul	Director	知情买入	10,000	$2.34	$23.4K	33,370
2020-10-05	Vuori Kristiina Md	Director	未知	-	-	-	-
2020-10-05	Vuori Kristiina Md	Director	限制性股票授予 (RSU)	35,000	$5.63	$197.05K	35,000
2020-07-08	Pande Atul	Director	知情买入	10,000	$2.73	$27.29K	23,370
2020-07-08	Cheruvu Pavan	Principal Executive Officer	知情买入	37,500	$2.74	$102.64K	57,836
2020-06-12	Nassif David W.	Principal Financial Officer	股份退回	15,060	-	-	15,060
2020-06-12	Corcoran Gavin	Chief R&d Officer	RSU 预扣税	6,211	$3.46	$21.49K	9,791
2020-06-11	Nassif David W.	Principal Financial Officer	RSU 预扣税	5,266	$3.25	$17.11K	18,944
2020-06-11	Cheruvu Pavan	Principal Executive Officer	RSU 预扣税	9,755	$3.09	$30.14K	20,336
2020-04-15	Nassif David W.	Principal Financial Officer	限制性股票授予 (RSU)	52,600	-	-	52,600
2020-04-15	Pande Atul	Director	限制性股票授予 (RSU)	17,500	$3.45	$60.38K	17,500
2020-04-15	Modig Berndt	Director	限制性股票授予 (RSU)	17,500	$3.45	$60.38K	17,500
2020-04-15	Torti Frank	Director	限制性股票授予 (RSU)	17,500	$3.45	$60.38K	17,500
2020-04-15	Cheruvu Pavan	Principal Executive Officer	限制性股票授予 (RSU)	112,700	-	-	112,700
2020-04-15	Corcoran Gavin	EVP of R&d	限制性股票授予 (RSU)	42,400	-	-	42,400
2020-04-15	Sundaram Senthil Vel	Director	限制性股票授予 (RSU)	17,500	$3.45	$60.38K	17,500
2020-03-16	Pande Atul	Director	知情买入	10,000	$1.78	$17.84K	13,370
2020-02-24	Roivant Sciences Ltd.	10 Percent Owner	知情买入	5,333,333	$3.75	$20M	18,577,380
2020-02-17	Venker Eric	Director	未知	-	-	-	-
2019-09-21	Nassif David W.	Principal Financial Officer	限制性股票授予 (RSU)	30,120	-	-	30,120
2019-09-21	Cheruvu Pavan	Principal Executive Officer	限制性股票授予 (RSU)	45,181	-	-	45,181
2019-09-21	Corcoran Gavin	EVP of R&d	限制性股票授予 (RSU)	32,003	-	-	32,003
2019-07-10	Viking Global Investors Lp	Officer	未知	-	-	-	-
2019-07-10	Viking Global Performance Llc	Officer	未知	-	-	-	-
2019-07-10	Qvt Associates Gp Llc	10 Percent Owner	未知	-	-	-	-
2019-07-10	Dexxon Holdings Ltd.	Officer	未知	-	-	-	-
2019-07-10	Svf Investments (uk) Ltd	Officer	未知	-	-	-	-
2019-07-10	Machado Patrick	Officer	未知	-	-	-	-
2019-07-10	Lo Andrew	Officer	未知	-	-	-	-
2019-07-01	Nassif David W.	Principal Financial Officer	处置	-	-	-	9,150
2019-07-01	Nassif David W.	Principal Financial Officer	限制性股票授予 (RSU)	75,000	$6.42	$481.5K	75,000
2019-06-27	Sundaram Senthil Vel	Director	未知	-	-	-	-
2019-06-27	Sundaram Senthil Vel	Director	限制性股票授予 (RSU)	18,750	$6.19	$116.06K	18,750